HENGRUI PHARMA(01276.HK)

Last Updated 08:00:00
longbridge loading
Company Encyclopedia
View More
name
HENGRUI PHARMA
01276.HK
Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. The company develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China.
1.248 T
01276.HKMarket value -Rank by Market Cap -/-

Financial Score

19/05/2026 Update
B
PharmaceuticalsIndustry
Industry Ranking1/53
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreA
    • ROE14.68%A
    • Profit Margin24.93%A
    • Gross Margin86.60%A
  • Growth ScoreB
    • Revenue YoY14.59%B
    • Net Profit YoY21.90%B
    • Total Assets YoY47.14%A
    • Net Assets YoY42.81%A
  • Cash ScoreB
    • Cash Flow Margin141.23%B
    • OCF YoY14.59%B
  • Operating ScoreC
    • Turnover0.53C
  • Debt ScoreA
    • Gearing Ratio10.02%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Pre-market trend | HENGRUI PHARMA (1276.HK) on May 13th surged with increased volume leading the pharmaceutical sector, is the bullish momentum about to start?

    Technical Forecast·
    HK
    01276
    -2.69%
    Technical Forecast·
    HK
    01276
    -2.69%

    BMS and Hengrui forge $15.2bn alliance for early-stage drugs

    Pharmaceutical Technology·
    SH
    600276
    -1.60%
    US
    BMY
    +0.54%
    HK
    01276
    -2.69%
    Pharmaceutical Technology·
    SH
    600276
    -1.60%
    US
    BMY
    +0.54%
    HK
    01276
    -2.69%

    China’s Hengrui Jumps After Inking USD15 Billion Innovative Drug Deal With BMS

    Yicai·
    HK
    01276
    -2.69%
    SH
    600276
    -1.60%
    SH
    520880
    0.00%
    Yicai·
    HK
    01276
    -2.69%
    SH
    600276
    -1.60%
    SH
    520880
    0.00%

    China’s Hengrui seals US$15.2 billion deal with US pharmaceutical giant BMS

    SCMP·
    US
    BMY
    +0.54%
    HK
    01276
    -2.69%
    US
    PILL
    -5.60%
    SCMP·
    US
    BMY
    +0.54%
    HK
    01276
    -2.69%
    US
    PILL
    -5.60%

    Top 5 HK Stock Gainers/Losers (>100B) (5.12)

    Top Gainers&Losers·
    HK
    06656
    -6.57%
    HK
    01276
    -2.69%
    HK
    01766
    +2.51%
    Top Gainers&Losers·
    HK
    06656
    -6.57%
    HK
    01276
    -2.69%
    HK
    01766
    +2.51%
    © 2026 Longbridge｜Disclaimer